Tracking hope: new Drug's Real-World impact on postpartum depression
NCT ID NCT07398469
Summary
This study aims to understand how symptoms of postpartum depression change after people start taking zuranolone, a prescription medication for this condition. Researchers will follow 200 participants in the U.S. who have a new prescription, asking them to complete short online surveys about their symptoms at 15, 45, and 90 days after their first dose. The goal is to gather real-world information on how well the drug works and its use in daily life, without changing anyone's prescribed medical care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTPARTUM DEPRESSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Biogen
RECRUITINGCambridge, Massachusetts, 02142, United States
Contact
Conditions
Explore the condition pages connected to this study.